{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:54:46Z","timestamp":1781783686442,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024724","name":"Manchester Clinical Research Facility","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011022","name":"Vertex Pharmaceuticals Incorporated","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jcf.2025.12.020","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T12:38:20Z","timestamp":1767011900000},"page":"225-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessing the reliability of upper airway sampling for microbiological surveillance in cystic fibrosis"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1353-950X","authenticated-orcid":false,"given":"Gisli G","family":"Einarsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4050-8330","authenticated-orcid":false,"given":"Andrew J","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6326-4431","authenticated-orcid":false,"given":"Peter J","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3891-1906","authenticated-orcid":false,"given":"Hafsa","family":"Nauman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7055-6034","authenticated-orcid":false,"given":"Paul S","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn A","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M","family":"Tunney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9008-2502","authenticated-orcid":false,"given":"Robert W","family":"Lord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2025.12.020_bib0001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011044","article-title":"Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients","volume":"5","author":"Cox","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcf.2025.12.020_bib0002","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/j.1462-2920.2010.02173.x","article-title":"Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa","volume":"12","author":"Klepac-Ceraj","year":"2010","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.jcf.2025.12.020_bib0003","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1073\/pnas.1120577109","article-title":"Decade-long bacterial community dynamics in cystic fibrosis airways","volume":"109","author":"Zhao","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcf.2025.12.020_bib0004","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: the 2018 revision","volume":"17","author":"Castellani","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.12.020_bib0005","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02153-2022","article-title":"Longitudinal effects of elexacaftor\/tezacaftor\/ivacaftor on sputum viscoelastic properties, airway infection and inflammation in patients with cystic fibrosis","volume":"62","author":"Schaupp","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2025.12.020_bib0006","series-title":"Cystic Fibrosis Foundation 2023 Annual Data Report","year":"2023"},{"key":"10.1016\/j.jcf.2025.12.020_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116029","article-title":"Comparison of microbiomes from different niches of upper and lower airways in children and adolescents with cystic fibrosis","volume":"10","author":"Boutin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jcf.2025.12.020_bib0008","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1513\/AnnalsATS.201407-310OC","article-title":"Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods","volume":"12","author":"Zemanick","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2025.12.020_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222323","article-title":"Upper versus lower airway microbiome and metagenome in children with cystic fibrosis and their correlation with lung inflammation","volume":"14","author":"Kirst","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jcf.2025.12.020_bib0010","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02235-2016","article-title":"Concordance between upper and lower airway microbiota in infants with cystic fibrosis","volume":"49","author":"Prevaes","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2025.12.020_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109798","article-title":"The microbial community of the cystic fibrosis airway is disrupted in early life","volume":"9","author":"Renwick","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jcf.2025.12.020_bib0012","doi-asserted-by":"crossref","first-page":"13769","DOI":"10.1073\/pnas.1107435109","article-title":"Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota","volume":"109","author":"Goddard","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcf.2025.12.020_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.107002","article-title":"The relationship between lung disease severity and the sputum proteome in cystic fibrosis","volume":"204","author":"Maher","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.jcf.2025.12.020_bib0014","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/nmeth.2634","article-title":"Practical innovations for high-throughput amplicon sequencing","volume":"10","author":"Lundberg","year":"2013","journal-title":"Nat methods"},{"key":"10.1016\/j.jcf.2025.12.020_bib0015","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1038\/s41467-020-17041-7","article-title":"Analysis of compositions of microbiomes with bias correction","volume":"11","author":"Lin","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcf.2025.12.020_bib0016","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.2517-6161.1982.tb01195.x","article-title":"The Statistical Analysis of Compositional Data","volume":"44","author":"Aitchison","year":"1982","journal-title":"J R Stat Soc: B"},{"key":"10.1016\/j.jcf.2025.12.020_bib0017","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S2213-2600(18)30171-1","article-title":"The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial","volume":"6","author":"Ronchetti","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2025.12.020_bib0018","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jcf.2023.10.019","article-title":"Influence of highly effective modulator therapy on the sputum proteome in cystic fibrosis","volume":"23","author":"Maher","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.12.020_bib0019","series-title":"UK Cystic Fibrosis Registry Annual Data Report 2016","author":"Trust","year":"2017"},{"key":"10.1016\/j.jcf.2025.12.020_bib0020","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00128-2017","article-title":"Community analysis and co-occurrence patterns in airway microbial communities during health and disease","volume":"5","author":"Einarsson","year":"2019","journal-title":"ERJ open res"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325025512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325025512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:36:56Z","timestamp":1781782616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199325025512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1569199325025512"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2025.12.020","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the reliability of upper airway sampling for microbiological surveillance in cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2025.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}